Lifecore Biomedical to Showcase Injectables Expertise at Three Boston Conferences
Event summary
- Lifecore Biomedical will participate in three industry conferences in Boston between October 19 and November 23, 2026.
- Ryan Swanson, Ph.D., will speak on high-dose/viscosity peptide delivery at PODD on October 30.
- The company will host meetings with prospective customers to discuss injectable program development and manufacturing services.
- Lifecore will have booths at CDMO Live Americas (C19) and PODD (109), with booth details for the American Pharma Summit to be determined.
The big picture
Lifecore's participation in these conferences underscores the growing importance of strategic partnerships in the CDMO sector. As biopharmaceutical companies increasingly outsource complex injectable development, Lifecore's ability to showcase its 40-year expertise could position it as a key player in this high-growth market. The focus on high-dose/viscosity formulations aligns with industry trends toward more complex therapeutic delivery systems.
What we're watching
- Customer Acquisition
- The pace at which Lifecore secures new partnerships from these conferences will indicate its market traction.
- Technical Differentiation
- Whether Ryan Swanson's panel discussion elevates Lifecore's expertise in high-dose/viscosity formulations.
- Competitive Positioning
- How Lifecore's presence at these events compares to competitors in the CDMO space.